ZA92510B - Vaccine composition against influenza,with synergic effects,containing influenza virus core as an additive - Google Patents

Vaccine composition against influenza,with synergic effects,containing influenza virus core as an additive

Info

Publication number
ZA92510B
ZA92510B ZA92510A ZA92510A ZA92510B ZA 92510 B ZA92510 B ZA 92510B ZA 92510 A ZA92510 A ZA 92510A ZA 92510 A ZA92510 A ZA 92510A ZA 92510 B ZA92510 B ZA 92510B
Authority
ZA
South Africa
Prior art keywords
additive
vaccine composition
influenza virus
composition against
virus core
Prior art date
Application number
ZA92510A
Other languages
English (en)
Inventor
Catherine Moste-Deshairs
Moste-Deshairs Catherine
Bernard Meignier
Meignier Bernard
Original Assignee
Pasteur Merieux Serums Vacc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9409015&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA92510(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pasteur Merieux Serums Vacc filed Critical Pasteur Merieux Serums Vacc
Publication of ZA92510B publication Critical patent/ZA92510B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • A61K39/145Orthomyxoviridae, e.g. influenza virus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525Virus
    • A61K2039/5252Virus inactivated (killed)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511Organic adjuvants
    • A61K2039/55566Emulsions, e.g. Freund's adjuvant, MF59
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/70Multivalent vaccine
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011Details
    • C12N2760/16011Orthomyxoviridae
    • C12N2760/16111Influenzavirus A, i.e. influenza A virus
    • C12N2760/16122New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011Details
    • C12N2760/16011Orthomyxoviridae
    • C12N2760/16111Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA92510A 1991-01-24 1992-01-24 Vaccine composition against influenza,with synergic effects,containing influenza virus core as an additive ZA92510B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9100806A FR2671974A1 (fr) 1991-01-24 1991-01-24 Composition vaccinale contre la grippe, a effet synergique, contenant comme additif du core de virus grippal.

Publications (1)

Publication Number Publication Date
ZA92510B true ZA92510B (en) 1992-11-25

Family

ID=9409015

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA92510A ZA92510B (en) 1991-01-24 1992-01-24 Vaccine composition against influenza,with synergic effects,containing influenza virus core as an additive

Country Status (10)

Country Link
EP (1) EP0522138B2 (enExample)
AT (1) ATE234861T1 (enExample)
AU (1) AU654699B2 (enExample)
CA (1) CA2078985C (enExample)
DE (1) DE69232962T3 (enExample)
FR (1) FR2671974A1 (enExample)
IL (1) IL100765A (enExample)
NZ (1) NZ241398A (enExample)
WO (1) WO1992013002A1 (enExample)
ZA (1) ZA92510B (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2156525A1 (en) * 1993-02-19 1994-09-01 Susan Dillon Influenza vaccine compositions containing 3-o-deacylated monophosphoryl lipid a
FR2723740B1 (fr) * 1994-08-16 1996-11-08 Pasteur Merieux Serums Vacc Procede de preparation d'antigenes du virus grippal, antigenes obtenus et leurs applications
AU7126998A (en) * 1997-04-16 1998-11-11 Connaught Laboratories Inc. Anti-influenza compositions supplemented with neuraminidase

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2483779A1 (fr) * 1980-06-05 1981-12-11 Synthelabo Procede pour isoler des antigenes glycoproteiques viraux et son application a la preparation de vaccins
GB8502096D0 (en) * 1985-01-28 1985-02-27 Medical Res Council Influenza vaccine
US5136019A (en) * 1989-05-24 1992-08-04 Sri International Synthetic peptides for diagnosis and prevention of influenza virus infection and their use

Also Published As

Publication number Publication date
FR2671974A1 (fr) 1992-07-31
CA2078985C (fr) 2004-11-09
NZ241398A (en) 1994-08-26
EP0522138B1 (fr) 2003-03-19
DE69232962T3 (de) 2007-11-08
DE69232962D1 (de) 2003-04-24
DE69232962T2 (de) 2005-06-23
FR2671974B1 (enExample) 1995-03-03
AU654699B2 (en) 1994-11-17
IL100765A0 (en) 1992-09-06
EP0522138B2 (fr) 2007-02-14
WO1992013002A1 (fr) 1992-08-06
IL100765A (en) 1996-06-18
CA2078985A1 (fr) 1992-07-25
AU1248792A (en) 1992-08-27
ATE234861T1 (de) 2003-04-15
EP0522138A1 (fr) 1993-01-13

Similar Documents

Publication Publication Date Title
MY104685A (en) Substituted thiazoles and their use as fungicides.
BR9205818A (pt) Composições azeotrópicas de 1,1,2,2-tetrafluororetano e semelhantes.
IL96458A0 (en) Isoxazolines,their preparation,and their use as plantprotecting agents
NO944377D0 (no) Kjölemiddelblandinger
MY109233A (en) Compositions useful in the manufacture of golfballs
DK0608912T3 (da) Synergistiske mikrobicide sammensætninger
DE69202822D1 (de) Silikonmodifizierte wässrige Überzugszusammensetzung.
ZA929155B (en) Wound healing compositions and methods for preparing and using same.
AP9400621A0 (en) Influenza vaccine compositions
ES2058346T3 (es) Compuestos piperidinilicos 1,4-disustituidos.
DE68906011D1 (de) Chitosan enthaltendes kosmetisches praeparat.
EA199900069A1 (ru) Вакцинная композиция против малярии
NO900612D0 (no) Preservativ for vandige sammensetninger.
MX24890A (es) Polipeptido sintetico, procedimiento par su preparacion y composicion farmaceutica que lo contiene.
IL116010A0 (en) Immunogenic compositions
DE58902899D1 (de) 2',3'-dideoxypurinnucleosid/purinnucleosid-phosphorylase-inhibitor kombinationstherapie und zusammensetzungen dafuer.
AU1815899A (en) Method and composition to enhance the efficacy of a vaccine using chemokines
DE69003075D1 (de) Stabilisierungszusammensetzungen.
ZA92510B (en) Vaccine composition against influenza,with synergic effects,containing influenza virus core as an additive
FI893721A0 (fi) Synergistisk soetningskomposition och preparat innehaollande densamma.
AU1485192A (en) Crop-protecting compositions containing isoxazolines or isothiazolines, novel isoxazolines and isothiazolines, and their preparation
NZ226677A (en) Avian vaccine and composition against e.coli
ES2013025A6 (es) Un metodo para preparar 24r-escimnol.
EP0457127A3 (en) Spermicidal coating
ES2069960T3 (es) Agente o concentrado para la conservacion de madera y materiales de madera.